跳至主要内容
临床试验/KCT0005590
KCT0005590尚未招募未知

Clinical trials for the expansion of indications of endoscopic ultrasound-guided radiofrequency ablation in patients with pancreatic tumors

Asan Medical Center0 个研究点目标入组 38 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 80(Year)(—)
性别
All

入选标准

  • 1. Persons who are able to understand clinical trials of Adults under the age of 20 and under 80 years old who are voluntarily agreed to participate in this clinical trial, voluntarily agreeing to sign consent for this clinical trial.
  • 2. Patients who have been diagnosed with tumors of pancreas and pancreatic tumors using biopsy.
  • 3. Patients who are inoperable or can be operated but not wanted
  • 4. Estimated expectation period of 6 months or more.
  • 5. tumor is identified by CT, MRI or EUS
  • 6. Patients with = 50 % of Karnofsky performance status
  • 7. Patient whose results are normal in the blood coagulation test
  • 8. Patients who follow the clinical trial procedure and comply with the visit schedule.

排除标准

  • 1. Patient who can not see images of endoscopic ultrasonography.
  • 2. Patients who are taking drugs that can cause bleeding, such as aspirin.
  • 3. Chronic obstructive or restrictive chronic lung disease, including breathing difficulty during recess
  • 4. Other serious diseases or medical conditions.
  • 5. Other medical condition that may impair the ability of patients to participate in clinical trials.
  • 6. Patients with significant neurologic or psychiatric disorder, such as dementia or strokes.

研究者

相似试验